Clinical Trial Update: Effects of Pulsatile Intravenous Insulin Therapy on Metabolic Integrity in Patients With Diabetes Mellitus [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating pulsatile intravenous insulin therapy for metabolic integrity in diabetes mellitus with complications has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus with Complications

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Florida Atlantic University | Conditions: Diabetes Mellitus, With Complications | Phase 2, Phase 3 | Status: TERMINATED